Dr. Simona  Rapposelli
My Social Links

Dr. Simona Rapposelli

Assistant Professor
University of Pisa, Italy


Highest Degree
Ph.D. in Medicinal Chemistry from University of Pisa, Italy

Share this Profile

Area of Interest:

Chemistry
100%
Myocardial Ischemia
62%
Neurodegenerative Diseases
90%
Alzheimer`s Disease
75%
Medicinal Chemistry
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
0
Abstracts
0

Selected Publications

  1. Zhu, D., M. Chen, M. Li, B. Luo and Y. Zhao et al., 2013. Discovery of novel N-substituted carbazoles as neuroprotective agents with potent anti-oxidative activity. Eur. J. Med. Chem., 68C: 81-88.
    CrossRef  |  Direct Link  |  
  2. Nesi, G., S. Sestito, V. Mey, S. Ricciardi and M. Falasca et al., 2013. Synthesis of novel 3,5-disubstituted-2-oxindole derivatives as antitumor agents against human nonsmall cell lung cancer. ACS Med. Chem. Lett., 4: 1137-1141.
    CrossRef  |  Direct Link  |  
  3. Martelli, A., L. Testai, V. Citi, A. Marino and I. Pugliesi et al., 2013. Arylthioamides as H2S donors: l-cysteine-activated releasing properties and vascular effects in vitro and in vivo. ACS Med. Chem. Lett., 4: 904-908.
    CrossRef  |  Direct Link  |  
  4. Rapposelli, S., A. Coi, M. Imbriani and A.M. Bianucci, 2012. Development of classification models for identifying true P-glycoprotein (P-gp) inhibitors through inhibition, ATPase activation and monolayer efflux assays. Int. J. Mol. Sci., 13: 6924-6943.
    CrossRef  |  PubMed  |  
  5. Huang, W.Y., X.J. Chao, Y. Ouyang, A.M. Liu and X.X. He et al., 2012. Tacrine-6-ferulic acid, a novel multifunctional dimer against Alzheimer's disease, prevents oxidative stress-induced neuronal death through activating Nrf2/ARE/HO-1 Pathway in HT22 cells. CNS Neurosci. Therapeutics, 18: 950-952.
    CrossRef  |  
  6. Chiellini, G., S. Rapposelli, J. Zhu, I. Massarelli and M. Saraceno et al., 2012. Synthesis and biological activities of vitamin D-like inhibitors of CYP24 hydroxylase. Steroids, 77: 212-223.
    CrossRef  |  Direct Link  |  
  7. Chao, X.J., X.X. He, Y.L. Yang, X. Zhou and M.H. Jin et al., 2012. Design, synthesis and pharmacological evaluation of novel tacrine-caffeic acid hybrids as multi-targeted compounds against Alzheimers disease. Bioorg. Med. Chem. Lett., 22: 6498-6502.
    CrossRef  |  Direct Link  |  
  8. Rapposelli, S., M.C. Breschi, V. Calderone, M. Digiacomo and A. Martelli et al., 2011. Synthesis and biological evaluation of 5-membered spiro heterocycle-benzopyran derivatives against myocardial ischemia. Eur. J. Med. Chem., 46: 966-973.
    CrossRef  |  Direct Link  |  
  9. Rapposelli, S., F. da Settimo, M. Digiacomo, C. La Motta, A. Lapucci, S. Sartini and M. Vanni, 2011. Synthesis and Biological Evaluation of 2′-Oxo-2,3-dihydro-3′H- spiro[chromene-4,5′-[1,3]oxazolidin]-3′yl]acetic acid derivatives as aldose reductase inhibitors. Arch. Pharm. (Weinheim), 344: 372-385.
    CrossRef  |  Direct Link  |  
  10. Rapposelli, S., 2011. The importance of stereochemistry in medicinal chemistry and drug discovery. Curr. Top. Med. Chem., 11: 758-759.
  11. Rapposelli, S., 2011. Novel ATP-sensitive potassium channel ligands: a patent overview (2005-2010). Exp. Opinion Therapeutic Patents, 21: 355-379.
  12. Rapposelli, S., M. Digiacomo, S. Franchi, S. Moretti, M. Pinza, P. Sacerdote and A. Balsamo, 2010. Sodium N-(methylsulfonyl)-N-(4-nitro-2-phenoxyphenyl)sulfamate: a water-soluble nimesulide prodrug for parenteral use. Mol. Pharm., 7: 1871-1876.
    CrossRef  |  PubMed  |  
  13. Calderone, V., L. Testai, A. Martelli, S. Rapposelli, M. Digiacomo, A. Balsamo and M.C. Breschi, 2010. Anti-ischemic properties of a new spiro-cyclic benzopyran activator of the cardiac mitoKATP channel. Biochem. Pharmacol., 79: 39-47.
    CrossRef  |  Direct Link  |  
  14. Rapposelli, S., M. Digiacomo and A. Balsamo, 2009. P-gp transporter and its role in neurodegenerative diseases. Curr. Top. Med. Chem., 9: 209-217.
  15. Rapposelli, S, V. Calderone, R. Cirilli, M. Digiacomo and C. Faggi et al., 2009. Enantioselectivity in Cardioprotection induced by (S)-(−)-2,2-Dimethyl-N-(4′-acetamido-benzyl)-4-spiromorpholone-chromane. J. Med. Chem., 52: 1477-1480.
  16. Minutolo, F., S. Bertini, C. Granchi, T. Marchitiello and G. Prota et al., 2009. Structural evolutions of salicylaldoximes as selective agonists for estrogen receptor β. J. Med. Chem., 52: 858-867.
    CrossRef  |  Direct Link  |  
  17. Coi, A., A.M. Bianucci, V. Calderone, L. Testai, M. Digiacomo, S. Rapposelli and A. Balsamo, 2009. Predictive models, based on classification algorithms, for compounds potentially active as mitochondrial ATP-sensitive potassium channel openers. Bioorg. Med. Chem., 17: 5565-5571.
    CrossRef  |  Direct Link  |  
  18. Calderone, V., S. Rapposelli, A. Martelli, M. Digiacomo and L. Testai et al., 2009. NO-glibenclamide derivatives: Prototypes of a new class of nitric oxide-releasing anti-diabetic drugs. Bioorg. Med. Chem., 17: 5426-5432.
    CrossRef  |  Direct Link  |  
  19. Rapposelli, S., S. Cuboni, M. Digiacomo, A. Lucacchini, F. Minutolo, M.L. Trincavelli and A. Balsamo, 2008. Synthesis and affinity evaluation for at1 receptor of phenylsalicylaldoxime-derivatives structurally related to sartans. Heterocycles, 75: 1467-1478.
    Direct Link  |  
  20. Rapposelli, S., S. Cuboni, M. Digiacomo, A. Lapucci, M.L. Trincavelli, T. Tuccinardi and A. Balsamo, 2008. Synthesis and AT1 affinity evaluation of benzamidophenyl analogs of known AT1 receptor ligands with similar aromatic skeleton. ARKIVOC., 2: 268-286.
    Direct Link  |  
  21. Minutolo, F., R. Bellini, S. Bertini, I. Carboni and A. Lapucci et al., 2008. Monoaryl-substituted salicylaldoximes as ligands for estrogen receptor. J. Med. Chem., 51: 1344-1351.
  22. Colabufo, N.A., F. Berardi, R. Perrone, S. Rapposelli, M. Digiacomo, M. Vanni and A. Balsamo, 2008. Synthesis and biological evaluation of (Hetero)arylmethyloxy- and arylmethylamine-phenyl derivatives as potent P-glycoprotein modulating agents. J. Med. Chem., 51: 1415-1422.
  23. Colabufo, N.A., F. Berardi, R. Perrone, S. Rapposelli, M. Digiacomo, M. Vanni and A. Balsamo, 2008. 2-[(3-Methoxyphenylethyl)phenoxy]-based ABCB1 inhibitors: Effect of different basic side-chains on their biological properties. J. Med. Chem., 51: 7602-7613.
    CrossRef  |  Direct Link  |  
  24. Calderone, V., M. Digiacomo, A. Martelli, F. Minutolo, S. Rapposelli, L. Testai and A. Balsamo, 2008. Evaluation of the NO-releasing properties of NO-donor linkers. J. Pharm. Pharmacol., 60: 189-195.
    CrossRef  |  Direct Link  |  
  25. Breschi, M.C., V. Calderone, M. Digiacomo, M. Manganaro and A. Martelli et al., 2008. Spirocyclic Benzopyran-based derivatives as new anti-ischemic activators of mitochondrial ATP-sensitive potassium channel. J. Med. Chem., 51: 6945-6954.
    CrossRef  |  Direct Link  |  
  26. Balsamo, A., V. Calderone and S. Rapposelli, 2008. New emerging prospects in the pharmacotherapy of hypertension cardiovasc hematol agents. Med. Chem., 6: 1-19.
  27. Asso, V., E. Ghilardi, S. Bertini, M. Digiacomo and C. Granchi et al., 2008. Α-Naphthylaminopropan-2-ol derivatives as BACE1 inhibitors. Chem. Med. Chem., 3: 1530-1534.
  28. Testai, L., S. Rapposelli and V. Calderone, 2007. Cardiac ATP-sensitive potassium channels, a potential target for an anti-ischaemic pharmacological strategy. Cardiovasc. Haematol. Agents Med. Chem., 5: 79-90.
  29. Orlandini, E., S. Rapposelli, S. Nencetti, G. Giannaccini, L. Betti and A. Balsamo, 2007. Synthesis and 5-HT2A, 5-HT1A and alpha1-binding affinities of 2-[2-Hydroxy-3-(pyridin-3-yl-methyl)amino]-, 2-[2-hydroxy-3-(2-pyridin-2-yl-ethyl)amino]- and 2-[2-hydroxy-3-(4-N-methyl-piperazin-1-yl)-amino]propoxybenzaldehyde-O-(substituted) benzyl oximes. Arch. Pharm., 340: 135-139.
  30. Calderone, V., L. Testai, A. Martelli, S. Rapposelli and M.C. Breschi, 2007. Activators of cardiac mitochondrial ATP-sensitive potassium channels: Promising drugs for anti-ischaemic therapy. Curr. Topics Pharmacol., 11: 81-90.
  31. Tuccinardi, T., V. Calderone, S. Rapposelli and A. Martinelli, 2006. Proposal of a new binding orientation for non-peptide AT1 antagonists:  Homology modeling, docking and three-dimensional quantitative structure: Activity relationship analysis. J. Med. Chem., 49: 4305-4316.
    CrossRef  |  
  32. Tuccinardi, T., S. Bertini, A. Martinelli, F. Minutolo and G. Ortore et al., 2006. Synthesis of anthranylaldoxime derivatives as estrogen receptor ligands and computational prediction of binding modes. J. Med. Chem., 49: 5001-5012.
    CrossRef  |  Direct Link  |  
  33. Minutolo, F., S. Bertini, L. Betti, R. Danesi and G. Gervasi et al., 2006. Synthesis of stable analogues of geranylgeranyl diphosphate possessing a (Z,E,E)-geranylgeranyl side chain, docking analysis, and biological assays for prenyl protein transferase inhibition. Chem. Med. Chem., 1: 218-224.
    CrossRef  |  Direct Link  |  
  34. Minutolo, F., S. Bertini, A. Martinelli, G. Ortore and G. Placanica et al., 2006. Salicylaldoximes and anthranylaldoximes as alternatives to phenol-based estrogen receptor ligands. Joint Italian-Swiss Med. Chem. Meeting, 8: 83-94.
    CrossRef  |  Direct Link  |  
  35. Martelli, A., S. Rapposelli and V. Calderone, 2006. NO-releasing hybrids of cardiovascular drugs. Curr. Med. Chem., 13: 609-625.
    CrossRef  |  Direct Link  |  
  36. Colabufo, N.A., F. Berardi, R. Perrone, S. Rapposelli, M. Digiacomo and A. Balsamo, 2006. Arylmethyloxyphenyl derivatives:  Small molecules displaying P-glycoprotein inhibition. J. Med. Chem., 49: 6607-6613.
    CrossRef  |  Direct Link  |  
  37. Breschi, M.C., V. Calderone, M. Digiacomo, M. Macchia and A. Martelli et al., 2006. New no-releasing pharmacodynamic hybrids of losartan and its active metabolite:  Design, synthesis and biopharmacological properties. J. Med. Chem., 49: 2628-2639.
    CrossRef  |  Direct Link  |  
  38. Breschi, M.C., V. Calderone, A. Martelli, F. Minutolo, S. Rapposelli, L. Testai, F. Tonelli and A. Balsamo, 2006. New benzopyran-based openers of the mitochondrial KATP potassium channel with potent anti-ischaemic properties. J. Med. Chem., 49: 7600-7602.
  39. Rossello, A., E. Nuti, M.P. Catalani, P. Carelli and E. Orlandini et al., 2005. A new development of matrix metalloproteinase inhibitors: Twin hydroxamic acids as potent inhibitors of MMPs. Bioorg. Med. Chem. Lett., 15: 2311-2314.
    CrossRef  |  Direct Link  |  
  40. Minutolo, F., V. Asso, S. Bertini, L. Betti and M. Ciriaco et al., 2005. Variously substituted (phosphonoacetamido)oxy analogues of geranylgeranyl diphosphate (GGdP) as GGdP-transferase (GGTase) inhibitors and antiproliferative agents. Med. Chem., 1: 239-244.
    CrossRef  |  Direct Link  |  
  41. Minutolo, F., G. Sala, A. Bagnacani, S. Bertini and I. Carboni et al., 2005. Synthesis of a resveratrol analogue with high ceramide-mediated proapoptotic activity on human breast cancer cells. J. Med. Chem., 48: 6783-6786.
    CrossRef  |  Direct Link  |  
  42. Rossello, A., E. Orlandini, E. Nuti, S. Rapposelli, M. Macchia, E. di Modugno and A. Balsamo, 2004. Synthesis and antimicrobial activity of new 7β-(benzo[a] dihydrocarbazolyloxyacetyl)-substituted cephalosporins. Farmaco, 59: 691-696.
    CrossRef  |  Direct Link  |  
  43. Rossello, A., E. Nuti, E. Orlandini, P. Carelli and S. Rapposelli et al., 2004. New N-arylsulfonyl-N-alkoxyaminoacetohydroxamic acids as selective inhibitors of gelatinase A (MMP-2). Bioorg. Med. Chem., 12: 2441-2450.
  44. Rapposelli, S., A. Lapucci, F. Minutolo, E. Orlandini, G. Ortore, M. Pinza and A. Balsamo, 2004. Synthesis and COX-2 inhibitory properties of N-phenyl- and N-phenyl-and< i> N-benzyl-substituted amides of 2-(4-methylsulfonylphenyl)cyclopent-1-ene-1-carboxylic acid and of their pyrazole, thiophene and isoxazole analogs. Farmaco, 59: 25-31.
    CrossRef  |  Direct Link  |  
  45. Minutolo, F., V. Asso, S. Bertini, L. Betti and G. Gervasi et al., 2004. Stable propylphosphonic acid analogues of geranylgeranyl diphosphate possessing inhibitory activity on geranylgeranyl protein transferase. Farmaco, 59: 857-861.
    CrossRef  |  Direct Link  |  
  46. Minutolo, F., M. Antonello, S. Bertini, G. Placanica and S. Rapposelli et al., 2004. Diaryl-substituted salicyl- and anthranyl-ketoximes as potential estrogen receptor ligands. Farmaco, 59: 601-607.
    CrossRef  |  Direct Link  |  
  47. Minutolo, F., M. Antonello, S. Barontini, S. Bertini and L. Betti et al., 2004. Phosphonomethylphosphorylmethyl(oxy)-analogues of geranylgeranyl diphosphate as stable and selective geranylgeranyl protein transferase inhibitors. Farmaco, 59: 887-892.
    CrossRef  |  Direct Link  |  
  48. Breschi, M.C., V. Calderone, M. Digiacomo, A. Martelli and E. Martinotti et al., 2004. NO-sartans:  A new class of pharmacodynamic hybrids as cardiovascular drugs. J. Med. Chem., 47: 5597-5600.
    CrossRef  |  Direct Link  |  
  49. Minutolo, F., S. Bertini, L. Betti, V. Di Bussolo and G. Giannaccini et al., 2003. Synthesis of aniline-type analogues of farnesyl diphosphate and their biological assays for prenyl protein transferase inhibitory activity. Farmaco, 58: 1277-1281.
    CrossRef  |  Direct Link  |  
  50. Minutolo, F., S. Bertini, L. Betti, R. Danesi and G. Gervasi et al., 2003. Stable analogs of geranylgeranyl diphosphate possessing improved geranylgeranyl versus farnesyl protein transferase inhibitory selectivity. Bioorg. Med. Chem. Lett., 13: 4405-4408.
  51. Minutolo, F., M. Antonello, S. Bertini, S. Rapposelli and A. Rossello et al., 2003. Synthesis, binding affinity, and transcriptional activity of hydroxy- and methoxy-Substituted 3,4-Diarylsalicylaldoximes on estrogen receptors and Bioorg. Med. Chem., 11: 1247-1257.
  52. Minutolo, F., M. Antonello, S. Bertini, G. Ortore and G. Placanica et al., 2003. Novel estrogen receptor ligands based on an anthranylaldoxime structure: Role of the phenol-type pseudocycle in the binding process. J. Med. Chem., 46: 4032-4042.
  53. Macchia, M., S. Bertini, S. Fogli, E. Giovannetti, F. Minutolo, S. Rapposelli and R. Danesi, 2003. Ceramide analogues in apoptosis: a new strategy for anticancer drug development. Farmaco, 58: 205-211.
    CrossRef  |  Direct Link  |  
  54. Macchia, M., M. Antonello, S. Bertini, V. Di Bussolo and S. Fogli et al., 2003. Conformationally restrained ceramide analogues: Effects of lipophilic modifications on the antiproliferative activity. Farmaco, 58: 85-89.
    CrossRef  |  Direct Link  |  
  55. Balsamo, A., I. Coletta, A. Guglielmotti, C. Landolfi and F. Mancini et al., 2003. Synthesis of heteroaromatic analogues of (2-aryl-1-cyclopentenyl-1-alkylidene)-(arylmethyloxy)amine COX-2 inhibitors: Effects on the inhibitory activity of the replacement of the cyclopentene central core with pyrazole, thiophene or isoxazole ring. Eur. J. Med. Chem., 38: 157-168.
    CrossRef  |  Direct Link  |  
  56. Balsamo, A., F. Mancini, C. Milanese, E. Orlandini and G. Ortore et al., 2003. Synthesis and prostaglandin synthase inhibitory activity of new aromatic O-alkyloxime ethers substituted with methylsulfonamido or methylsulfonyl groups on their aliphatic portion. Farmaco, 58: 707-714.
    CrossRef  |  Direct Link  |  
  57. Rossello, A., S. Bertini, A. Lapucci, M. Macchia and A. Martinelli et al., 2002. Synthesis, antifungal activity and molecular modeling studies of new inverted oxime ethers of oxiconazole. J. Med. Chem., 45: 4903-4912.
    CrossRef  |  Direct Link  |  
  58. Balsamo, A., I. Coletta, P. Domiano, A. Guglielmotti and C. Landolfi et al., 2002. (E)-[2-(4-Methylsulphonylphenyl)-1-cyclopentenyl-1-methyliden](arylmethyloxy)amines. Methyleneaminoxymethyl (MAOM) analogues of diarylcyclopentenyl cyclooxygenase-2 inhibitors: Synthesis and biological properties. Eur. J. Med. Chem., 37: 391-398.
    CrossRef  |  Direct Link  |  
  59. Balsamo, A., I. Coletta, A. Guglielmotti, C. Landolfi and A. Lapucci et al., 2002. Aryl-substituted methyleneaminoxymethyl (MAOM) analogues of diarylcyclopentenyl yclooxygenase-2 inhibitors: Effects of some structural modifications on their biological properties. Eur. J. Med. Chem., 37: 585-594.
    CrossRef  |  Direct Link  |  
  60. Balsamo, A., S. Bertini, G. Gervasi, A. Lapucci and S. Nencetti et al., 2001. Enantiopure 3-(arylmethylidene)aminoxy-2-methylpropionic acids: Synthesis and antiinflammatory properties. Eur. J. Med. Chem., 36: 799-807.
    CrossRef  |  Direct Link  |  
  61. Balsamo, A., G. Cercignani, D. Gentili, A. Lapucci and M. Macchia et al., 2001. Synthesis and inhibitory activity towards human leukocyte elastase of new 7-methoxy and 7-chloro(2-acyloxymethyl)cephem derivatives. Eur. J. Med. Chem., 36: 185-193.